FDA Approves KINERET® (anakinra) for the Treatment of Deficiency of IL-1 Receptor Antagonist (DIRA)

NEXT STORY
Horseracing Integrity and Safety Act to Ban Doping Signed Into Law
PREV STORY
Provation, Healthcare IT Leader, Pilots Online Clinical Content Shop Offering Downloadable Evidence-Based Order Sets and Care Plans
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CoLucid Pharmaceuticals Announces Appointment of Dr. Raymond Skwierczynski as Head, Pharmaceutical Operations

CAMBRIDGE, Mass., Dec. 8, 2015 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (Nasdaq:CLCD), a Phase ...

author_avatar
NASDAQ Market News

Landmark Nature Publication Demonstrates the Power of the Fluidigm Hyperion Imaging System to Identify Novel Cellular Signatures That Correlate with Distinct Clinical Outcomes

author_avatar
NASDAQ Market News

Aptose Biosciences and CrystalGenomics Announce Issuance of Australian Patent for CG-806

author_avatar
NASDAQ Market News